Horich William Todd
SEC insider (Form 3/4/5 filer). CIK 0002117599. SVP, Commercial Operations at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2026. Located in ROCKVILLE, MD.
Companies Horich William Todd has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Officer, SVP, Commercial Operations
Horich William Todd
CIK: 0002117599
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 10, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect4.4K shares at avg. $55.00$244K - Mar 9, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect4.4K shares at avg. $54.00$240K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect3.8K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.7K shares at avg. $54.73$94K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect2.6K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect521 shares at avg. $54.73$29K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect1.1K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.2K shares at avg. $54.73$67K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 10, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 4,439 | $55.00 | $244,145 | Direct |
| Mar 9, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 4,438 | $54.00 | $239,652 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 3,750 | - | $0 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,718 | $54.73 | $94,026 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 2,625 | - | $0 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 521 | $54.73 | $28,514 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 1,125 | - | $0 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,216 | $54.73 | $66,552 | Direct |
1-8 of 8 transactions